Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Framçois SPERTINI, MD

Femme et Homme Max 99 ans
Framçois SPERTINI, MD MAJ Il y a 4 ans

Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment Study aiming to evaluate the efficacy of a 2-month pre-seasonal treatment with an AllerT 50 µg or 100 µg maintenance dose administered in previous study AN004T in reducing symptoms of alle...

Pays Denmark, France, Latvia, Lithuania, Poland, Sweden, Switzerland
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations